Genotoxicity/Mutagenicity Study

• Use the test article dissolved or suspended in a vehicle compatible with bacterial exposure, vehicle control, strain-specific positive controls, minimal glucose agar plates, molten top agar containing trace histidine/biotin for Salmonella or tryptophan for E. coli, and an S9 metabolic activation mixture when metabolic activation is required.

• The readout is colony formation by revertant bacteria.

• Use sterile culture tubes, pipettes, incubator set at 37°C, agar plates, colony counter or equivalent manual counting system, and standard microbiological equipment for culturing and plating tester strains.

• Prepare fresh overnight bacterial cultures of the selected tester strains and confirm strain suitability according to reported Ames practice, including appropriate spontaneous revertant behavior and responsiveness to positive controls.

• Prepare test article concentrations covering at least five analysable dose levels when feasible;
• Published Ames protocols commonly include testing up to 5,000 µg/plate or 5 mg/plate for soluble, non-cytotoxic substances, with lower top concentrations when cytotoxicity or poor solubility prevents analysis.

• Prepare assays in both the absence and presence of S9 mix to distinguish direct-acting mutagens from compounds requiring metabolic activation.

• For the plate-incorporation method, combine bacterial culture, test article or control, and S9 mix or buffer with molten top agar, pour the mixture onto minimal agar plates, allow the overlay to solidify, and incubate plates at 37°C for about 48 hours before counting revertant colonies.

• For the preincubation method, incubate bacterial culture with test article or control and S9 mix or buffer before adding molten top agar and plating; this format is reported as useful when pre-exposure improves detection, including for some nitrosamines.

• Use vehicle control plates to define background reversion and use strain-appropriate positive controls to confirm assay responsiveness;
• Reported examples include sodium azide for TA100/TA1535, 2-nitrofluorene for TA98, 9-aminoacridine for TA1537, 2-aminoanthracene with S9 activation, and alkylating agents for E. coli WP2 strains.

• Count revertant colonies for each strain, dose level, and metabolic activation condition, then compare treated plates with concurrent vehicle controls and evaluate whether increases are dose-related, reproducible, and biologically meaningful.

• A positive call should not rely only on an arbitrary statistical threshold;
• Published analyses describe common 2-fold or 3-fold rules but recommend integrating fold increase, dose-response, reproducibility, background range, cytotoxicity, and expert biological judgment.

• For nitrosamine-focused testing, studies report that sensitivity may improve with preincubation, TA100/TA1535 and WP2 uvrA or WP2 uvrA(pKM101), and induced liver S9, with some studies finding higher sensitivity under hamster S9 or higher S9-percentage conditions.

Problem: Few or no colonies appear on both vehicle and treated plates.

• Possible Cause: The bacterial culture or plating conditions may not support expected spontaneous reversion.
• Literature-supported Solution: Repeat the assay using validated overnight cultures and confirm strain performance with concurrent vehicle and positive controls before interpreting test article results.

Problem: Positive controls fail to increase revertant colonies.

• Possible Cause: The strain, positive-control chemical, S9 mix, or assay condition may be unsuitable.
• Literature-supported Solution: Use strain-appropriate positive controls and repeat the assay only after the positive-control response confirms assay sensitivity.

Problem: Heavy bacterial toxicity prevents dose interpretation.

• Possible Cause: The test article concentration is cytotoxic under the tested condition.
• Literature-supported Solution: Interpret only analysable concentrations and reduce the top dose or dose spacing when cytotoxicity prevents colony recovery.

Problem: A nitrosamine gives weak or discordant results.

• Possible Cause: Standard plate incorporation or suboptimal metabolic activation may reduce sensitivity for some nitrosamines.
• Literature-supported Solution: Use a preincubation design and include sensitive strains such as TA100, TA1535, and WP2 uvrA/WP2 uvrA(pKM101) with induced S9 activation conditions supported by nitrosamine studies.